These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Tschöpe C; Kasner M; Westermann D; Gaub R; Poller WC; Schultheiss HP Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646 [TBL] [Abstract][Full Text] [Related]
8. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. Bruch C; Rothenburger M; Gotzmann M; Sindermann J; Scheld HH; Breithardt G; Wichter T J Am Soc Echocardiogr; 2006 May; 19(5):522-8. PubMed ID: 16644435 [TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. Iwanaga Y; Nishi I; Furuichi S; Noguchi T; Sase K; Kihara Y; Goto Y; Nonogi H J Am Coll Cardiol; 2006 Feb; 47(4):742-8. PubMed ID: 16487838 [TBL] [Abstract][Full Text] [Related]
10. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Dong H; Chen DQ; Wang Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908 [TBL] [Abstract][Full Text] [Related]
11. Changes in the amplitude of electrocardiogram QRS complexes during follow-up of heart failure patients. Kataoka H; Madias JE J Electrocardiol; 2011; 44(3):394.e1-9. PubMed ID: 21376341 [TBL] [Abstract][Full Text] [Related]
12. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670 [TBL] [Abstract][Full Text] [Related]
13. The use of natriuretic peptides in the intensive care unit. Pirracchio R; Logeart D; Noveanu M; Mebazaa A; Mueller C Curr Opin Crit Care; 2008 Oct; 14(5):536-42. PubMed ID: 18787446 [TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of the B type natriuretic peptide, electrocardiography, and portable echocardiography for the assessment of patients from the community with suspected heart failure. Lim TK; Dwivedi G; Hayat S; Collinson PO; Senior R Echocardiography; 2007 Mar; 24(3):228-36. PubMed ID: 17313633 [TBL] [Abstract][Full Text] [Related]
15. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Felker GM; Hasselblad V; Hernandez AF; O'Connor CM Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866 [TBL] [Abstract][Full Text] [Related]
20. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]